Calithera Biosciences (CALA) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free CALA Stock Alerts $0.03 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaSustainabilityStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCalithera Biosciences (NASDAQ:CALA) Research Coverage Started at StockNews.comamericanbankingnews.com - April 22 at 2:16 AMArcus Biosciences Inc (RCUS)uk.investing.com - February 24 at 2:50 AMChristina Calanpr.org - August 12 at 3:20 AMCalithera Biosciences cancels special meeting due to lack of quorumseekingalpha.com - June 29 at 11:41 PMCALA - Calithera Biosciences, Inc.finance.yahoo.com - June 1 at 12:52 AMCalithera Biosciences, Inc.: Calithera Biosciences Announces Update on Complete Liquidation and Dissolutionfinanznachrichten.de - May 20 at 9:20 AMCala Mariolutravel.usnews.com - May 19 at 6:19 PMCalithera Biosciences plans special meeting to seek approval for liquidation and dissolution planseekingalpha.com - May 19 at 6:19 PMCalithera Biosciences Announces Update on Complete Liquidation and Dissolutionfinance.yahoo.com - May 19 at 6:19 PMCala Llombardstravel.usnews.com - May 13 at 4:01 PMCalithera Biosciences Inc (CALA) Earnings Dates & Reportsinvesting.com - May 12 at 7:58 PMCalithera Biosciences Shares Plummet on Liquidation Plans >CALAmarketwatch.com - January 11 at 3:24 PMCalithera Biosciences to Liquidate >CALAmarketwatch.com - January 11 at 3:24 PMBiotech company Calithera plans its own death. Will others follow?finance.yahoo.com - January 10 at 1:14 PMCalithera Biosciences, Inc.: Calithera Biosciences Announces Board Approval of Complete Liquidation and Dissolutionfinanznachrichten.de - January 9 at 2:15 PMCalithera Biosciences Board Of Directors Determine Dissolution Of Companymarkets.businessinsider.com - January 9 at 2:15 PMCalithera Biosciences Stock Nosedives On Complete Liquidation, Dissolutionfinance.yahoo.com - January 9 at 2:15 PMCalithera Biosciences Announces Board Approval of Complete Liquidation and Dissolutionfinance.yahoo.com - January 9 at 8:27 AMmarketbeat.com - January 9 at 7:58 AMCalithera Biosciences, Inc.: Calithera Biosciences Reports Third Quarter 2022 Financial Results and Business Updatefinanznachrichten.de - November 15 at 10:25 PMCalithera Biosciences, Inc. (CALA) Q3 2022 Earnings Call Transcriptseekingalpha.com - November 15 at 11:28 AMCalithera Biosciences Reports Third Quarter 2022 Financial Results and Business Updatefinance.yahoo.com - November 15 at 11:28 AMCalithera Biosciences to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022finance.yahoo.com - November 8 at 7:38 PMCalithera Biosciences Gets FDA Fast Track For Lung Cancer Drugmarketwatch.com - October 3 at 10:48 AMCalithera Gets FDA Fast Track Designation For Sapanisertib For Squamous Lung Cancer Treatmentnasdaq.com - October 3 at 10:48 AMCalithera Receives FDA Fast Track Designation for Sapanisertib for the Treatment of NRF2-mutated Squamous Lung Cancerfinance.yahoo.com - October 3 at 10:48 AMCalithera's stock is up 14% after announcing Fast Track designation for lung-cancer drug candidatefinance.yahoo.com - October 3 at 10:48 AMCALA Calithera Biosciences, Inc.seekingalpha.com - October 1 at 12:31 PMCalithera Biosciences Increuters.com - September 21 at 5:10 AM3 Penny Stocks With Surprisingly Superior Fundamentalsfinance.yahoo.com - September 17 at 2:43 AMCalithera to Present at the H.C. Wainwright 24th Annual Global Investment Conferencefinance.yahoo.com - September 6 at 4:15 PMCompanies Like Calithera Biosciences (NASDAQ:CALA) Could Be Quite Riskyfinance.yahoo.com - August 16 at 12:19 PMCalithera Biosciences Reports Second Quarter 2022 Financial Results and Recent Highlightsfinance.yahoo.com - August 16 at 7:13 AMCalithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q2 2022 Results - Earnings Call Transcriptseekingalpha.com - August 16 at 7:13 AMEarnings Preview For Calithera Biosciencesmsn.com - August 12 at 4:02 PMCalithera Biosciences to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022finance.yahoo.com - August 8 at 8:40 PMCalithera Biosciences Shares Progress in Sapanisertib and Mivavotinib Clinical Programs at Upcoming Lung Cancer and Lymphoma Conferencesapnews.com - July 13 at 5:34 PMCalithera Biosciences Shares Progress in Sapanisertib and Mivavotinib Clinical Programs at Upcoming Lung Cancer and Lymphoma Conferencesfinance.yahoo.com - July 13 at 5:34 PMCalithera Biosciences Announces First Patient Enrolled in Phasetmcnet.com - July 6 at 6:42 PMCalithera Biosciences Announces First Patient Enrolled in Phase 2 Clinical Trial of Sapanisertib in Relapsed/Refractory NRF2 (NFE2L2)-Mutated Squamous Non-Small Cell Lung Cancerfinance.yahoo.com - July 6 at 6:42 PMWhat is a Reverse Stock Split and How Does it Work?finance.yahoo.com - July 5 at 4:25 AMCalithera Commences Mid-Stage Study Of DLBCL Candidatebenzinga.com - June 23 at 8:35 PMCalithera Biosciences Announces First Patient Enrolled in Phase 2 Clinical Trial of Mivavotinib in Relapsed/Refractory non-GCB (ABC) Diffuse Large B-Cell Lymphomafinance.yahoo.com - June 23 at 8:35 PMCalithera Biosciences, Inc.: Calithera Biosciences Announces 1-for-20 Reverse Stock Splitfinanznachrichten.de - June 15 at 2:52 AMCalithera Biosciences announces 1-for-20 reverse stock split to regain listing complianceseekingalpha.com - June 14 at 4:51 PMCalithera Biosciences Announces 1-for-20 Reverse Stock Splitfinance.yahoo.com - June 14 at 4:51 PMAfter a record-breaking decade, biotech is discovering what hard times feel likefinance.yahoo.com - May 27 at 9:59 AMCalithera to Present at the H.C. Wainwright Global Investment Conferencefinance.yahoo.com - May 17 at 8:37 AMCalithera Biosciences stock slips after PT cut at Ladenburgseekingalpha.com - May 11 at 1:19 PMCalithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q1 2022 Results - Earnings Call Transcriptseekingalpha.com - May 11 at 1:44 AM Get Calithera Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CALA and its competitors with MarketBeat's FREE daily newsletter. Email Address The "Smart Money" Is Ready for May 1st Are You? (Ad)Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. One Former Wall St. Trader Explains Why… CALA Media Mentions By Week CALA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CALA News Sentiment▼0.000.44▲Average Medical News Sentiment CALA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CALA Articles This Week▼10▲CALA Articles Average Week Get Calithera Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CALA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ATHX News Today APVO News Today AMPE News Today ALLR News Today ADTX News Today BLPH News Today SXTC News Today EVFM News Today EVLO News Today NEPT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CALA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calithera Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
